Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:504-505
Published online before print January 19, 2004, doi: 10.1161/01.HYP.0000113818.62697.de
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/2/504    most recent
01.HYP.0000113818.62697.dev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

(Hypertension. 2004;43:504.)
© 2004 American Heart Association, Inc.


Awards

19th Annual Aventis Pharma Hypertension Research Clinical Fellowship Program Award


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The purpose of this program and research award is to stimulate physicians-in-training to pursue a career in clinical research in hypertension. The research fellow must be conducting work in which he or she is the major senior investigator in any area of the researcher’s choice, including clinical or laboratory aspects of the hypertensive diseases. The fellow’s work would be supervised by the director of the research training program (the mentor), but the conduct of the investigation is primarily by the research fellow. The winning presentation receives $3,000, and the fellow’s mentor receives $25,000 to support the clinical investigative training of a research fellow the following year. Dr Oscar H. Cingolani is the recipient of this award for 2003.Down


Figure Removed (Available Only in the Full Text)
View larger version (148K):
[in this window]
[in a new window]
 
Dr. Ernesto Schiffrin (right), Dr. Oscar Cingolani (center), Dr. Robert Carey (left).

Dr Oscar Cingolani received his medical degree from the University of La Plata, La Plata, Argentina. Subsequently, he received 4 years training in internal medicine at the University of Buenos Aires, Argentina. He remained at this institution for 2 years as chief of inpatient care. Subsequently, Dr Cingolani spent 2 years as a postdoctoral research fellow in the Hypertension and Vascular Research Division, Department of Internal Medicine, at Henry Ford Hospital, Detroit, Mich. He is currently in the Internal Medicine Residency Program, the Reading Hospital and Medical Center, West Reading, Pa. Dr Cingolani received this award for his work titled "Cardiac Collagen-Targeted Treatment Reduced Systolic Performance Without Affecting Diastolic Compliance in Spontaneously Hypertensive Rats." This work was performed under the . . . [Full Text of this Article]